Standard Operating Procedure for Material Dispensing for IV Injection Manufacturing

1. Purpose

To define a standardized procedure for dispensing raw materials used in the manufacturing of intravenous (IV) injections, ensuring compliance with GMP, WHO, and ICH guidelines. The SOP ensures traceability, accuracy in dispensing, and sterility assurance.

2. Scope

This SOP applies to all raw material dispensing activities related to the manufacturing of intravenous injections at the Sterile Injectable Manufacturing unit. It covers activities from receipt of material requisition to final transfer to the cleanroom staging area.

3. Responsibilities

• Stores Executive: Responsible for physical dispensing of materials as per requisition.
• Quality Assurance (QA) Officer: Ensures compliance with SOP and monitors documentation and line clearance.
• Production Chemist: Verifies and receives dispensed materials before manufacturing.
• Quality Control (QC): Reviews the CoA and conducts necessary sampling and testing.

4. Accountability

The Head of Sterile Injectable Manufacturing is accountable for ensuring strict compliance with this SOP, proper training of personnel, and timely review of records.

5. Procedure

5.1 Receiving and Preliminary Inspection

1. Receive the approved Batch Manufacturing Record (BMR) or Material Requisition Note (MRN) from the production department.
2. Cross-check material names, quantities, batch numbers, and storage conditions.
3. Inspect material containers for integrity, label clarity, and shelf-life validity.
4. Ensure approved status and CoA availability before proceeding to dispense.

5.2 Documentation and Verification

1. Record each item in the Material Dispensing Log (Annexure-1).
2. Verify the Certificate of Analysis (CoA) of each material (Annexure-2).
3. Ensure the weighed quantity is within specified tolerance (±0.1%).
4. Use calibrated weighing balances and ensure calibration tags are valid.

5.3 Dispensing and Handling of Materials

1. Sanitize the outer surface of containers using 70% IPA prior to bringing them into the weighing booth.
2. Dispense materials in a controlled environment — classified area with reverse laminar airflow (RLAF).
3. Use pre-cleaned, labeled stainless steel or plastic containers for dispensing.
4. Close lids immediately after weighing to prevent contamination.

5.4 Labeling, Approval, and Release of Materials

1. Affix “Dispensed” labels with material name, quantity, batch number, date of dispensing, and operator signature.
2. QA to review and approve each dispensed container using the Approval and Release Form (Annexure-3).
3. Transfer dispensed materials to the designated staging area near the cleanroom entrance.
4. Ensure physical segregation of materials to avoid cross-contamination.

5.5 Documentation and Record-Keeping

1. All entries must be in indelible ink with date, time, and signature.
2. Strike out errors with a single line and provide justification if needed.
3. Ensure all documentation is reviewed by QA before releasing materials for manufacturing.

6. Abbreviations

• SOP: Standard Operating Procedure
• IV: Intravenous
• CoA: Certificate of Analysis
• QA: Quality Assurance
• QC: Quality Control
• MRN: Material Requisition Note
• RLAF: Reverse Laminar Air Flow

7. Documents

1. Material Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• WHO GMP Guidelines for Sterile Products
• ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• Schedule M – Drugs and Cosmetics Rules, India

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Material Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Material Dispensing for IM Injection Manufacturing

1. Purpose

To define the standard procedure for dispensing raw materials required for the manufacturing of intramuscular (IM) injection formulations. This SOP ensures precision, traceability, and regulatory compliance under GMP, WHO, and ICH guidelines.

2. Scope

This SOP applies to all dispensing operations related to the preparation of intramuscular injection formulations conducted at the Sterile Injectable Manufacturing facility.

3. Responsibilities

• Warehouse Staff: Responsible for dispensing raw materials as per production requirements.
• Production Chemist: Reviews requisition and receives dispensed materials.
• QA Officer: Verifies dispensing records, ensures compliance, and authorizes material release.
• QC Personnel: Confirms material quality through CoA verification and sampling.

4. Accountability

The Head of Sterile Injectable Manufacturing is accountable for the implementation, compliance, and periodic review of this SOP.

5. Procedure

5.1 Receiving Material Requisition

1. Receive signed MRN from the Production department with material specifications, batch sizes, and required quantities.
2. Check that MRN is authorized and complete.

5.2 Verification and Line Clearance

1. Check material containers for intact packaging, labeling, and expiry status.
2. Review CoA and cross-verify against batch number and specification.
3. Ensure designated weighing area is cleaned and cleared (line clearance to be documented).

5.3 Material Weighing and Dispensing

1. Carry materials into the classified weighing booth under RLAF after sanitizing outer surfaces.
2. Use pre-cleaned containers and calibrated weighing balances with valid calibration status.
3. Dispense each material accurately within ±0.1% of the specified weight.
4. Document each weighing in the Material Dispensing Log (Annexure-1).

5.4 Labeling and QA Verification

1. Affix labels with details such as material name, quantity, batch number, date, and dispensed by.
2. Present all containers and documentation for QA verification.
3. QA to fill and sign the Approval and Release Form (Annexure-3).

5.5 Transfer and Documentation

1. Transfer labeled and approved materials to the pre-cleanroom staging area.
2. Ensure segregation of actives and excipients in transit.
3. Ensure all dispensing documentation is signed and filed for traceability.

6. Abbreviations

• SOP: Standard Operating Procedure
• IM: Intramuscular
• CoA: Certificate of Analysis
• MRN: Material Requisition Note
• QA: Quality Assurance
• QC: Quality Control
• RLAF: Reverse Laminar Air Flow

7. Documents

1. Material Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• WHO GMP Guidelines – Annex 6: Manufacture of Sterile Medicinal Products
• ICH Q7 – GMP for Active Pharmaceutical Ingredients
• Schedule M – Indian GMP Requirements

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Material Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Dispensing of Raw Materials for SC Injection Formulation

1. Purpose

To establish a uniform procedure for dispensing of raw materials intended for the manufacturing of subcutaneous (SC) injections. This ensures correct quantity, proper handling, and documentation in compliance with GMP, WHO, and ICH guidelines.

2. Scope

This SOP covers all dispensing operations for active ingredients and excipients used in the formulation of subcutaneous injection products at the Sterile Injectable Manufacturing department.

3. Responsibilities

• Store Executive: Handles material weighing and initial verification.
• QA Officer: Monitors compliance with SOP and signs off on dispensed materials.
• Production Chemist: Verifies and receives dispensed materials.
• QC Personnel: Verifies CoA and material suitability before release.

4. Accountability

The Head of Manufacturing is accountable for ensuring the implementation of this SOP and training of all related personnel.

5. Procedure

5.1 Material Request and Verification

1. Receive MRN from production with batch number, material details, and quantity.
2. Verify storage conditions, integrity of containers, and label clarity.
3. Cross-check material expiry, status label, and CoA availability.

5.2 Weighing Area Preparation

1. Ensure the RLAF unit is functioning and area is cleaned.
2. Place cleaned and calibrated weighing balances in position.
3. Sanitize outer surfaces of all containers with 70% IPA.

5.3 Dispensing Operations

1. Weigh each raw material individually under RLAF using pre-cleaned containers.
2. Use separate spatulas/scoops for each material to prevent contamination.
3. Record details in Material Dispensing Log (Annexure-1) immediately after weighing.
4. Ensure weighing accuracy within permissible limits of ±0.1%.

5.4 Labeling and Documentation

1. Affix label on each container with material name, quantity, batch number, date of dispensing, and operator signature.
2. Fill the Approval and Release Form (Annexure-3) and submit to QA.
3. Maintain traceability through batch linkage to MRN and BMR.

5.5 QA Review and Release

1. QA Officer checks container labels, quantities, and documentation.
2. Signs the release section and authorizes transfer to staging area.
3. Release approved materials to production with acknowledgment.

6. Abbreviations

• SOP: Standard Operating Procedure
• SC: Subcutaneous
• RLAF: Reverse Laminar Air Flow
• QA: Quality Assurance
• QC: Quality Control
• CoA: Certificate of Analysis
• MRN: Material Requisition Note

7. Documents

1. Material Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• ICH Q7 – GMP for APIs
• WHO GMP: Good Manufacturing Practices for Pharmaceutical Products
• Schedule M – Drugs and Cosmetics Rules

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Material Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Dispensing of Raw Materials for Intraosseous Injection Manufacturing

1. Purpose

To define a clear and standardized procedure for the dispensing of materials required for manufacturing intraosseous injections. This SOP ensures product safety, batch traceability, and adherence to current GMP practices.

2. Scope

This SOP is applicable to all personnel involved in the dispensing of raw materials for intraosseous injection products at the Sterile Injectable Manufacturing facility, including receipt, weighing, labeling, and release.

3. Responsibilities

• Warehouse Chemist: Carries out material dispensing and documentation.
• QA Executive: Conducts verification and approval of dispensed materials.
• Production Pharmacist: Receives and verifies materials before use.
• QC Analyst: Ensures analytical conformity of each material via CoA.

4. Accountability

The Head of Manufacturing shall ensure that all dispensing operations are performed as per this SOP and deviations are investigated and resolved.

5. Procedure

5.1 MRN Verification and Preparation

1. Review the Material Requisition Note (MRN) for completeness and proper authorization.
2. Cross-check the list of required materials against the approved BMR.
3. Ensure availability of valid CoAs and materials with status as “Approved.”

5.2 Weighing Area Control and Setup

1. Perform area cleaning using approved cleaning SOP.
2. Switch ON the RLAF unit and confirm airflow parameters before weighing begins.
3. Arrange labeled weighing tools and accessories in designated sanitized areas.

5.3 Material Weighing and Handling

1. Transport material containers to weighing area after external sanitization with 70% IPA.
2. Weigh materials individually, using pre-calibrated and certified weighing balances.
3. Dispense within the defined limits (±0.1%) as specified in the BMR.
4. Use different tools for different materials to prevent contamination.
5. Log weights in the Material Dispensing Log (Annexure-1) immediately.

5.4 Labeling and Verification

1. Label dispensed containers with: material name, quantity, batch no., dispensed by, date.
2. Complete the Approval and Release Form (Annexure-3) and submit to QA.
3. QA to perform physical verification and document in their review log.

5.5 Release and Transfer

1. After QA approval, materials shall be transferred to the staging area near the aseptic zone.
2. Materials to be segregated by product and labeled clearly to avoid mix-ups.
3. Submit all documentation to QA for archiving and retention.

6. Abbreviations

• SOP: Standard Operating Procedure
• IO: Intraosseous
• QA: Quality Assurance
• QC: Quality Control
• MRN: Material Requisition Note
• CoA: Certificate of Analysis
• BMR: Batch Manufacturing Record

7. Documents

1. Material Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• WHO TRS 961 Annex 6 – GMP for Sterile Products
• ICH Q9 – Quality Risk Management
• Schedule M – Good Manufacturing Practices (India)

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Material Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Dispensing of Raw Materials for Intradermal Injection Manufacturing

1. Purpose

To define the standardized procedure for the accurate and compliant dispensing of raw materials for intradermal (ID) injection manufacturing. This ensures accuracy, traceability, and compliance with GMP, WHO, and ICH guidelines.

2. Scope

This SOP is applicable to all activities involved in the dispensing of raw materials—active ingredients and excipients—used in the formulation of intradermal injections at the Sterile Injectable Manufacturing department.

3. Responsibilities

• Stores Chemist: Responsible for physical dispensing, weighing, and labeling of materials.
• QA Officer: Monitors SOP compliance, verifies documentation, and authorizes release.
• Production Officer: Ensures correct material is received and used per batch requirements.
• QC Analyst: Confirms material suitability based on CoA and retesting as needed.

4. Accountability

The Head of Manufacturing is accountable for the implementation, compliance, and periodic review of this SOP.

5. Procedure

5.1 Material Request Review

1. Receive Material Requisition Note (MRN) from production with all required details.
2. Cross-verify with the Batch Manufacturing Record (BMR) for quantities and specification alignment.
3. Ensure materials are approved, within expiry, and accompanied by valid CoAs.

5.2 Dispensing Area Preparation

1. Ensure dispensing booth is cleaned, sanitized, and the RLAF unit is operational.
2. Review equipment logbooks to confirm cleaning and calibration status.
3. Arrange pre-cleaned utensils and containers in the designated area.

5.3 Weighing and Dispensing

1. Clean the outer surfaces of material containers with 70% IPA.
2. Bring materials into the weighing booth one at a time to prevent mix-up.
3. Dispense raw materials using calibrated balances. Tolerance: ±0.1%.
4. Use designated scoops/utensils for each material to avoid cross-contamination.
5. Record details immediately in the Material Dispensing Log (Annexure-1).

5.4 Labeling and QA Review

1. Label each dispensed material with the name, batch no., quantity, date, and operator initials.
2. QA officer verifies dispensed quantity, CoA, label, and documentation.
3. Fill the Approval and Release Form (Annexure-3) and obtain QA signature.

5.5 Release to Production

1. Transfer labeled materials to staging area under appropriate conditions.
2. Production personnel verify receipt and sign the acknowledgment.
3. File all original records in the batch folder for traceability and audit readiness.

6. Abbreviations

• SOP: Standard Operating Procedure
• ID: Intradermal
• MRN: Material Requisition Note
• BMR: Batch Manufacturing Record
• QA: Quality Assurance
• QC: Quality Control
• CoA: Certificate of Analysis
• RLAF: Reverse Laminar Air Flow

7. Documents

1. Material Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• WHO TRS 986 Annex 2 – GMP for Sterile Pharmaceutical Products
• ICH Q10 – Pharmaceutical Quality System
• Schedule M – Indian GMP Requirements

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Material Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Dispensing of Components for Prefilled Syringe Manufacturing

1. Purpose

To define a detailed procedure for the controlled dispensing of sterile and critical components such as plungers, barrels, stoppers, and tip-caps used in prefilled syringe (PFS) manufacturing. This SOP ensures integrity, traceability, and compliance with cGMP requirements.

2. Scope

This SOP applies to all dispensing operations for primary packaging components used in prefilled syringes at the Sterile Injectable Manufacturing facility, covering receiving, cleaning verification, visual inspection, and documentation.

3. Responsibilities

• Warehouse Personnel: Responsible for dispensing, labeling, and recording of components.
• QA Executive: Verifies component cleanliness, documents compliance, and authorizes transfer.
• Production Operator: Receives, inspects, and verifies components prior to use.
• QC Analyst: Reviews CoA and sterility status of sterile components if applicable.

4. Accountability

The Head of Manufacturing shall ensure that only approved and sterile components are dispensed and tracked as per procedure. Non-compliance must be escalated for review.

5. Procedure

5.1 Material Request and Verification

1. Receive component requisition along with the BMR and production plan.
2. Verify availability, cleaning status, approval status, and packaging integrity.
3. Ensure all items are within expiry and carry appropriate status labels.

5.2 Visual Inspection and Clean Area Preparation

1. Perform 100% visual inspection of components for defects, black particles, scratches, or deformation.
2. Ensure dispensing area is sanitized and RLAF is operational with valid pressure and HEPA certification.
3. Arrange components and containers in a linear, segregated layout to prevent mix-ups.

5.3 Component Dispensing and Documentation

1. Open component packs only inside the RLAF using aseptic techniques.
2. Dispense the required number of pieces as per BMR with ±1% tolerance.
3. Document dispensing activity in the Component Dispensing Log (Annexure-1).
4. Ensure integrity of unused portions by resealing and labeling as “Partially Used – Not for Further Use” if single-use only.

5.4 Labeling and QA Release

1. Affix internal labels on all containers with: component name, quantity dispensed, date, operator initials.
2. Submit filled Approval and Release Form (Annexure-3) to QA for verification.
3. QA Officer signs off post-verification and authorizes staging for production.

5.5 Transfer to Aseptic Area

1. Transfer dispensed components in closed, sterile containers through approved material pass box.
2. Maintain separate movement logbook with time, quantity, and batch linkage.
3. Production to acknowledge receipt and perform visual re-verification before use.

6. Abbreviations

• SOP: Standard Operating Procedure
• PFS: Prefilled Syringe
• QA: Quality Assurance
• QC: Quality Control
• RLAF: Reverse Laminar Air Flow
• BMR: Batch Manufacturing Record

7. Documents

1. Component Dispensing Log – Annexure-1
2. Certificate of Analysis (CoA) – Annexure-2
3. Approval and Release Form – Annexure-3

8. References

• WHO GMP Guidelines – Annex 6: Manufacture of Sterile Medicinal Products
• ICH Q8/Q9 – Pharmaceutical Development and Risk Management
• Schedule M – Indian GMP for Sterile Product Packaging

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Component Dispensing Log

Annexure-2: Certificate of Analysis (CoA)

Annexure-3: Approval and Release Form

Revision History

Standard Operating Procedure for Weight Verification of Dispensed Materials in Sterile Injectable Manufacturing

1. Purpose

To establish a standardized procedure for verifying the weight of all raw materials dispensed for sterile injectable manufacturing. This SOP ensures that weights recorded are accurate, validated, and consistent with GMP requirements, thereby preventing batch failures and deviations.

2. Scope

This SOP applies to all raw materials dispensed for sterile injectable products where weight verification is required prior to batch charging. The process includes independent verification, documentation, and reconciliation of dispensed quantities.

3. Responsibilities

• Stores Chemist: Performs initial weighing and records preliminary weights.
• QA Executive: Independently verifies the weights and signs the verification log.
• Production Pharmacist: Cross-checks dispensed material against the BMR before charging.
• QC Analyst: Verifies weight accuracy where analytical verification is required.

4. Accountability

The Head of QA is accountable for ensuring that no material proceeds to production without verified weights and proper documentation as per this SOP.

5. Procedure

5.1 Preparation and Review

1. Receive MRN and approved BMR from the production department.
2. Ensure all dispensed containers are properly labeled with gross weight, tare weight, and net weight.
3. Check that weighing was performed using calibrated balances.

5.2 Independent Weight Verification

1. QA shall reweigh the container using the same balance or a qualified equivalent in the same area.
2. Verify that the net weight recorded is within the specified tolerance of ±0.1%.
3. Confirm container ID, material name, batch number, and reconcile labels.
4. Sign and date the Weight Verification Log (Annexure-1) immediately after confirmation.

5.3 Recording and Cross-Verification

1. Document the gross weight, tare weight, and net weight as observed by QA.
2. Attach weight verification log to the dispensing record set for QA filing.
3. Production pharmacist shall countersign upon receipt of verified materials.

5.4 Handling Discrepancies

1. If weight difference exceeds ±0.1%, investigate possible root cause (e.g., label error, balance drift).
2. Initiate a deviation report and inform QA Manager for further evaluation.
3. Repeat dispensing and verification if required after corrective action.

5.5 Documentation Requirements

1. Ensure all entries in the weight verification log are legible, traceable, and signed with full name and date.
2. Corrections must follow ALCOA+ principles and be justified in a footnote.
3. Retain all weight verification logs as part of the batch record file.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• QC: Quality Control
• BMR: Batch Manufacturing Record
• MRN: Material Requisition Note
• ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

1. Weight Verification Log – Annexure-1
2. Material Dispensing Record – Annexure-2
3. Deviation Report Form (if applicable) – Annexure-3

8. References

• WHO TRS 986 – Good Manufacturing Practices
• ICH Q9 – Quality Risk Management
• Schedule M – Indian GMP

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Weight Verification Log

Annexure-2: Material Dispensing Record

Annexure-3: Deviation Report Form

Revision History

Standard Operating Procedure for Labeling of Dispensed Materials in Sterile Injectable Manufacturing

1. Purpose

To describe the procedure for proper labeling of raw materials after dispensing to ensure traceability, accurate identification, segregation, and regulatory compliance with GMP standards for sterile injectable manufacturing.

2. Scope

This SOP is applicable to all dispensed raw materials (actives and excipients) at the sterile injectable manufacturing facility that are to be used in batch manufacturing.

3. Responsibilities

• Warehouse Staff: Responsible for generating and affixing correct labels to dispensed materials.
• QA Officer: Verifies label contents and correctness, signs off for approval.
• Production Pharmacist: Ensures labels match BMR entries before use.

4. Accountability

The Head of Warehouse is accountable for ensuring that no dispensed material leaves the area without a correct and compliant label as per this SOP.

5. Procedure

5.1 Preparation for Labeling

1. Use a printed template as per approved format for all labels to avoid manual errors.
2. Labels must be pre-approved by QA and bear controlled document status.

5.2 Label Format Requirements

1. Each label must contain the following information:
   • Material Name (as per BMR)
   • Material Code
   • Batch Number (Raw Material)
   • Quantity Dispensed (with units)
   • Date of Dispensing
   • Container Number (e.g., 1 of 3, 2 of 3)
   • Dispensed By (initials/signature)
2. Use waterproof adhesive labels printed with clear and legible font (minimum size: 10 pt).

5.3 Labeling Execution

1. Affix the label immediately after completion of each individual material weighing.
2. Ensure the label is securely adhered to the container and is not covering any critical markings.
3. In case of label damage or error, strike the label diagonally, attach a new one, and document the change.

5.4 QA Verification

1. QA shall verify each label against the MRN and BMR before approving it for material release.
2. Labels verified and signed by QA must not be altered without QA reapproval.

5.5 Label Storage and Control

1. Unused printed labels must be accounted for and destroyed in presence of QA.
2. Label issuance and destruction shall be documented in the Label Control Log (Annexure-3).

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• BMR: Batch Manufacturing Record
• MRN: Material Requisition Note

7. Documents

1. Label Template Record – Annexure-1
2. Labeling Verification Log – Annexure-2
3. Label Control Log – Annexure-3

8. References

• WHO GMP – Annex 6
• ICH Q10 – Pharmaceutical Quality System
• Schedule M – Good Manufacturing Practice (India)

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Label Template Record

Annexure-2: Labeling Verification Log

Annexure-3: Label Control Log

Revision History

Standard Operating Procedure for Handling and Dispensing of Sterile Components in Injectable Manufacturing

1. Purpose

To provide a detailed and validated procedure for aseptic handling and dispensing of sterile components such as filters, rubber stoppers, plungers, and glass vials in sterile injectable manufacturing. This SOP ensures compliance with GMP and maintains product sterility.

2. Scope

This SOP applies to all sterile components that are received, handled, visually inspected, and aseptically dispensed in the sterile component preparation areas of the injectable manufacturing facility.

3. Responsibilities

• Warehouse Executive: Responsible for receiving and issuing sterile components in appropriate packaging conditions.
• Aseptic Area Staff: Handles components under laminar airflow conditions using sterile techniques.
• QA Executive: Verifies sterility tags, inspection records, and approves batch usage.

4. Accountability

The Head of Manufacturing is accountable for implementation and oversight of this SOP, ensuring strict adherence to aseptic practices and documentation requirements.

5. Procedure

5.1 Receipt and Transfer

1. Receive sterile components from suppliers along with Certificate of Sterility and CoA.
2. Ensure all components are in double- or triple-layer sterile packaging with intact tamper-proof seals.
3. Transfer to sterile quarantine storage as per material movement SOP.

5.2 Verification and Visual Inspection

1. Inspect components for physical damage, color changes, particulate matter, and seal integrity under controlled lighting.
2. Record inspection results in the Sterile Component Inspection Log (Annexure-1).
3. Components failing visual inspection must be segregated and labeled “REJECTED.”

5.3 Area Preparation for Dispensing

1. Verify cleaning status of RLAF/laminar booth before use.
2. Perform sanitization using sterile 70% IPA and allow for contact time.
3. Ensure gowning is performed per aseptic entry SOP (validated garments, gloves, masks, etc.).

5.4 Aseptic Dispensing of Sterile Components

1. Open outer packaging of sterile components in outer zone, and inner sterile packs inside RLAF.
2. Use sterile forceps or gloved hands (disinfected with sterile IPA) to handle components.
3. Count and dispense as per BMR/BPR with ±1% tolerance.
4. Place components in sterile polybags or trays and seal immediately.
5. Affix sterile labels indicating name, quantity, date, and operator initials.

5.5 Documentation and Release

1. Record all dispensed quantities and traceability in the Component Dispensing Log (Annexure-2).
2. QA Officer to verify all documentation, inspection records, and approve release in Release Authorization Form (Annexure-3).

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• CoA: Certificate of Analysis
• BMR: Batch Manufacturing Record
• IPA: Isopropyl Alcohol
• RLAF: Reverse Laminar Air Flow

7. Documents

1. Sterile Component Inspection Log – Annexure-1
2. Component Dispensing Log – Annexure-2
3. Release Authorization Form – Annexure-3

8. References

• WHO TRS 961 Annex 6 – GMP for Sterile Medicinal Products
• ICH Q9 – Quality Risk Management
• Schedule M – Indian GMP

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Sterile Component Inspection Log

Annexure-2: Component Dispensing Log

Annexure-3: Release Authorization Form

Revision History

Standard Operating Procedure for Cross-Verification of Dispensed Materials in Sterile Injectable Manufacturing

1. Purpose

To establish a standardized procedure for the cross-verification of dispensed raw materials in sterile injectable manufacturing to ensure correctness in identity, quantity, labeling, and traceability. This SOP supports prevention of mix-ups and batch discrepancies.

2. Scope

This SOP is applicable to all cross-verification activities performed by designated personnel following material dispensing and prior to issuance to production within the sterile injectable manufacturing facility.

3. Responsibilities

• Stores Chemist: Dispenses materials and presents them for verification.
• QA Executive: Performs independent cross-verification of each dispensed item and signs off documentation.
• Production Pharmacist: Confirms material receipt matches BMR and verification records.

4. Accountability

The Head of QA is accountable for ensuring that cross-verification is performed for every dispensed material and no unverified material is transferred to manufacturing areas.

5. Procedure

5.1 Prerequisites

1. Ensure the Material Requisition Note (MRN) and approved Batch Manufacturing Record (BMR) are available.
2. Check that dispensing records are complete and weights recorded.
3. Ensure all labels are affixed and legible on dispensed containers.

5.2 Cross-Verification Steps

1. Verify the following attributes against the BMR and MRN:
   • Material name and code
   • Material batch/lot number
   • Quantity dispensed (weighed quantity vs. required)
   • Status label (“Approved” and valid)
   • Container label details (name, batch no., container no., date)
2. Ensure that the quantity dispensed is within ±0.1% of the specified amount.
3. Confirm physical integrity of the packaging (cleanliness, no tears, correct closure).

5.3 Documentation

1. Record verification results in the Cross-Verification Log (Annexure-1).
2. QA to sign and date next to each verified container and complete Verification Summary Form (Annexure-2).

5.4 Handling Discrepancies

1. If any mismatch or labeling error is observed, do not release the material.
2. Inform the QA Manager and raise a Dispensing Deviation Report (Annexure-3).
3. Perform corrective action, re-dispense if necessary, and document justification.

6. Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• MRN: Material Requisition Note
• BMR: Batch Manufacturing Record

7. Documents

1. Cross-Verification Log – Annexure-1
2. Verification Summary Form – Annexure-2
3. Dispensing Deviation Report – Annexure-3

8. References

• WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
• ICH Q10 – Pharmaceutical Quality System
• Schedule M – Indian GMP

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Cross-Verification Log

Annexure-2: Verification Summary Form

Annexure-3: Dispensing Deviation Report

Revision History